These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of thymosin on lymphocytes from patients with chronic mucocutaneous candidiasis and endocrinopathies. Akhter J; Merker RI; Rieger CH; Rothberg RM J Allergy Clin Immunol; 1980 Jan; 65(1):34-40. PubMed ID: 6985631 [No Abstract] [Full Text] [Related]
5. Transfer factor as an approach to the treatment of immune deficiency disease. Schulkind ML; Ayoub EM Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988 [TBL] [Abstract][Full Text] [Related]
7. Chronic mucocutaneous candidiasis, myositis, and thymoma. A new triad. Montes LF; Ceballos R; Cooper MD; Bradley MN; Bockman DE JAMA; 1972 Dec; 222(13):1619-23. PubMed ID: 4564702 [No Abstract] [Full Text] [Related]
8. Mucocutaneous candidiasis in a mother and son. Kroll JJ; Einbinder JM; Merz WG Arch Dermatol; 1973 Aug; 108(2):259-62. PubMed ID: 4579501 [No Abstract] [Full Text] [Related]
9. [Multifocal fungal infection in the course of ungual candidiasis]. Kwaśniewska J; Szymańska H Przegl Dermatol; 1981; 68(1):55-7. PubMed ID: 7244261 [No Abstract] [Full Text] [Related]
10. Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings. Axelsen NH; Kirkpatrick CH; Buckley RH Clin Exp Immunol; 1974 Jul; 17(3):385-94. PubMed ID: 4619788 [TBL] [Abstract][Full Text] [Related]
11. Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma. Maize JC; Lynch PJ Arch Dermatol; 1972 Jan; 105(1):96-8. PubMed ID: 5009626 [No Abstract] [Full Text] [Related]
12. [Management of paronychia]. Vakilzadeh F; Macher E Dtsch Med Wochenschr; 1974 Nov; 99(46):2363-4. PubMed ID: 4609719 [No Abstract] [Full Text] [Related]
13. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. Kirkpatrick CH; Green I; Rich RR; Schade AL J Infect Dis; 1971 Dec; 124(6):539-44. PubMed ID: 4942475 [No Abstract] [Full Text] [Related]
14. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Paterson PY; Semo R; Blumenschein G; Swelstad J Clin Exp Immunol; 1971 Nov; 9(5):595-602. PubMed ID: 4947556 [TBL] [Abstract][Full Text] [Related]
15. Non-candidal infections in children with chronic mucocutaneous candidiasis. Chipps BE; Saulsbury FT; Hsu SH; Hughes WT; Winkelstein JA Johns Hopkins Med J; 1979 Jun; 144(6):175-9. PubMed ID: 459201 [TBL] [Abstract][Full Text] [Related]
16. ROLE OF CANDIDA ALBICANS IN CHRONIC DISEASE. STONE OJ; MULLINS JF Arch Dermatol; 1965 Jan; 91():70-2. PubMed ID: 14229605 [No Abstract] [Full Text] [Related]
17. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Schulking ML; Adler WH; Altemeier WA; Ayoub EM Cell Immunol; 1972 Apr; 3(4):606-15. PubMed ID: 4554089 [No Abstract] [Full Text] [Related]
19. The cellular immune defect in chronic mucocutaneous candidiasis. Chilgren RA; Meuwissen HJ; Quie PG; Good RA; Hong R Lancet; 1969 Jun; 1(7609):1286-8. PubMed ID: 4182179 [No Abstract] [Full Text] [Related]
20. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor. Valdimarsson H; Wood CB; Hobbs JR; Holt PJ Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]